Company
Freya Biosciences
- Biotech
- Location:
- Copenhagen, Denmark
Description
Freya Biosciences develops clinical-stage immunology therapies that target inflammation and immune dysregulation to treat women’s health conditions such as infertility, preterm birth risk, and endometriosis by addressing underlying immune mechanisms rather than symptoms.
Freya Biosciences is located in the Copenhagen ecosystem.
Related
Hansa BiopharmaHansa Biopharma develops immunomodulating antibody-cleaving enzyme therapies that target and inactivate IgG antibodies, inhibiting…
ScientaLabScientaLab develops a foundation model that predicts human immune response in immunology and inflammation, using multi-disease,…
FimmCyte AGFimmCyte AG develops targeted immunotherapies that recognize a fibrosis-associated protein to selectively eliminate diseased fibrotic…
INNITIUSINNITIUS develops medical hardware and software that measure cervical tissue mechanical properties using torsional-wave sensing and AI to…
- TolerogenixxTolerogenixx develops personalized therapies using proprietary modified immune cell technology to target immune modulation, including…
LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
Enterprise TherapeuticsEnterprise Therapeutics researches and develops respiratory disease therapies, including inhaled ENaC blocker ETD001, to address mucus…
MinervaXMinervaX is developing a prophylactic Group B Streptococcal (GBS) vaccine, AlpN GBS, that works as a clinical-stage immunization product…
- GenmabGenmab develops antibody-based treatments for cancer and other serious diseases, creating proprietary antibody technologies incorporated…